Skip navigation
Skip to main content


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 12 (Search time: 0.001 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014A review of strategies to improve rational prescribing in asthma.Inam, S; Lipworth, W; Kerridge, I; Day, R
2014Challenges to pharmaceutical policymaking: lessons from Australia’s National Medicines PolicyLipworth, W; Kerridge, I; Doran, E; Day, R
2012Wrong questions, wrong answers? Are we getting the drugs we need?Lipworth, W; Kerridge, I; Day, R
2012No evidence or no alternative? Taking responsibility for off-label prescribingGhinea, N; Lipworth, W; Kerridge, I; Day, R
2012Time for the Pharmaceutical Benefits Advisory Committee to set its own agendaLipworth, W; Kerridge, I; Day, R
2011Death of the ‘Blockbuster’and ‘Pivotal’ Clinical Trial: Rethinking the Drug Development ProcessDay, R; Lipworth, W; Kerridge, I
2010Beyond rhetoric in debates about the ethics of marketing prescription medicines to consumers: The importance of vulnerability in people, situations and relationshipsCarter, SM; Samuel, GN Day R, Ankeny RA, Jordens CFC, Komesaroff P.; Kerridge, I; Day, R; Ankeny, R; Jordens, C; Komesaroff, P
2011How clinical and research failures lead to suboptimal prescribing: the example of chronic goutLipworth, W; Kerridge, I; Brett, J; Day, R
2013Overcoming entrenched disagreements. the case of misoprostol for post-partum haemorrhage.Ghinea, N; Lipworth, W; Little, M; Kerridge, I; Day, R
2014Ethics and Evidence in Medical Debates: The Case of Recombinant Activated Factor VIIGhinea, N; Lipworth, W; Kerridge, I; Little, M; Day, R